{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T17:24:13Z","timestamp":1782062653941,"version":"3.54.5"},"reference-count":22,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2021]]},"DOI":"10.3960\/jslrt.20048","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T22:07:21Z","timestamp":1616018841000},"page":"10-21","source":"Crossref","is-referenced-by-count":8,"title":["Follow-up with serum IgG4-monitoring in 8 patients with IgG4-related disease diagnosed by a lacrimal gland mass"],"prefix":"10.3960","volume":"61","author":[{"given":"Toshihiko","family":"Matsuo","sequence":"first","affiliation":[{"name":"Okayama University Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama City, Japan,"},{"name":"Department of Ophthalmology, Okayama University Hospital and Okayama University Medical School, Okayama City, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama City, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuharu","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Pathology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama City, Japan,"},{"name":"Division of Pathophysiology, Okayama University Graduate School of Health Sciences, Okayama City, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Hospital, Okayama City, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Uka","sequence":"additional","affiliation":[{"name":"Department of Radiology, Okayama University Hospital, Okayama City, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ennishi","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Okayama University Hospital, Okayama City, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomofumi","family":"Yano","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Okayama Rosai Hospital, Okayama City, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Sato Y, Notohara K, Kojima M <i>et al.<\/i> IgG4-related disease: historical overview and pathology of hematological disorders. Pathol Int. 2010; 60: 247-258.","DOI":"10.1111\/j.1440-1827.2010.02524.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Umehara H, Okazaki K, Masaki Y <i>et al.<\/i> Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012; 22: 21-30.","DOI":"10.3109\/s10165-011-0571-z"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Wallace ZS, Naden RP, Chari S <i>et al.<\/i> The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease. Arthritis Rheumatol. 2020; 72: 7-19.","DOI":"10.1002\/art.41120"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Wallace ZS, Naden RP, Chari S <i>et al.<\/i> The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020; 79: 77-87.","DOI":"10.1136\/annrheumdis-2019-216561"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Deshpande V, Zen Y, Chan JK <i>et al.<\/i> Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012; 25: 1181-1192.","DOI":"10.1038\/modpathol.2012.72"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Goto H, Takahira M, Azumi A. Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol. 2015; 59: 1-7.","DOI":"10.1007\/s10384-014-0352-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Matsuo T, Ichimura K, Sato Y <i>et al.<\/i> Immunoglobulin G4 (IgG4)-positive or -negative ocular adnexal benign lymphoid lesions in relation to systemic involvement. J Clin Exp Hematop. 2010; 50: 129-142.","DOI":"10.3960\/jslrt.50.129"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Matsuo T, Ichimura K, Yoshino T. Local recurrence as immunoglobulin G4 (IgG4)-related disease 10 years after radiotherapy to ocular adnexal extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. J Clin Exp Hematop. 2011; 51: 125-133.","DOI":"10.3960\/jslrt.51.125"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Andrew N, Kearney D, Selva D. IgG4-related orbital disease: a meta-analysis and review. Acta Ophthalmol. 2013; 91: 694-700.","DOI":"10.1111\/j.1755-3768.2012.02526.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum. 2014; 43: 806-817.","DOI":"10.1016\/j.semarthrit.2013.11.008"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Yu WK, Kao SC, Yang CF, Lee FL, Tsai CC. Ocular adnexal IgG4-related disease: clinical features, outcome, and factors associated with response to systemic steroids. Jpn J Ophthalmol. 2015; 59: 8-13.","DOI":"10.1007\/s10384-014-0353-1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Hong JW, Kang S, Song MK, Ahn CJ, Sa HS. Clinicoserological factors associated with response to steroid treatment and recurrence in patients with IgG4-related ophthalmic disease. Br J Ophthalmol. 2018; 102: 1591-1595.","DOI":"10.1136\/bjophthalmol-2017-311519"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Kubota T, Katayama M, Nishimura R, Moritani S. Long-term outcomes of ocular adnexal lesions in IgG4-related ophthalmic disease. Br J Ophthalmol. 2020; 104: 345-349.","DOI":"10.1136\/bjophthalmol-2018-313730"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Matsuo T, Ichimura K, Shinagawa K, Yoshino T. Different histopathological types of orbital lymphoma 16 years after systemic follicular lymphoma: immunohistochemical and immunogenetic analyses of two cases. J Clin Exp Hematop. 2008; 48: 17-24.","DOI":"10.3960\/jslrt.48.17"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Matsuo T, Ichimura K, Okada H <i>et al.<\/i> Clonal analysis of bilateral, recurrent, or systemically multifocal ocular adnexal lymphoma. J Clin Exp Hematop. 2010; 50: 27-38.","DOI":"10.3960\/jslrt.50.27"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Matsuo T, Ichimura K, Shinagawa K. Orbital MALT lymphoma, abdominal Hodgkin lymphoma, and systemic diffuse large B-cell lymphoma develop sequentially in one patient. J Clin Exp Hematop. 2012; 52: 41-49.","DOI":"10.3960\/jslrt.52.41"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Matsuo T, Tanaka T, Fujii N. Orbital MALT lymphoma after autologous stem cell transplantation for follicular lymphoma as relapse of diffuse large B-cell lymphoma. J Clin Exp Hematop. 2017; 56: 170-175.","DOI":"10.3960\/jslrt.56.170"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Matsuo T, Tanaka T, Kinomura M. Nephrotic syndrome during the tapering of oral steroids after pathological diagnosis of Kimura disease from a lacrimal gland mass: case report and review of 10 Japanese patients. J Clin Exp Hematop. 2017; 57: 147-152.","DOI":"10.3960\/jslrt.17028"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Matsuo T, Sato Y, Kuroda R, Matsuo N, Yoshino T. Systemic malignant lymphoma 17 years after bilateral orbital pseudotumor. Jpn J Ophthalmol. 2004; 48: 503-506.","DOI":"10.1007\/s10384-004-0095-6"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Ohno K, Sato Y, Ohshima K <i>et al.<\/i> A subset of ocular adnexal marginal zone lymphomas may arise in association with IgG4-related disease. Sci Rep. 2015; 5: 13539.","DOI":"10.1038\/srep13539"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Nishida K, Sogabe Y, Makihara A <i>et al.<\/i> Ocular adnexal marginal zone lymphoma arising in a patient with IgG4-related ophthalmic disease. Mod Rheumatol. 2019; 29: 383-387.","DOI":"10.1080\/14397595.2016.1216733"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Gion Y, Takeuchi M, Shibata R <i>et al.<\/i> Up-regulation of activation-induced cytidine deaminase and its strong expression in extra-germinal centres in IgG4-related disease. Sci Rep. 2019; 9: 761.","DOI":"10.1038\/s41598-018-37404-x"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/61\/1\/61_20048\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T04:34:10Z","timestamp":1616214850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/61\/1\/61_20048\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.20048","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}